Association of Medicaid expansion with mortality from gynecologic cancers
American Journal of Obstetrics and Gynecology Dec 14, 2020
Albright BB, Chino F, Chino JP, et al. - In March 2010, the Affordable Care Act was signed with the aim to improve health outcomes, mostly through coverage expansions and protections. Although universal implementation of most policies occurred, litigation delayed Medicaid expansion and ultimately made it an optional program for states. Using quasi-experimental, difference-in-difference methods, researchers here determined the correlation of Medicaid expansion with gynecologic cancer mortality. Assessing mortality data from the National Center for Health Statistics from 1999 to 2018, they identified reduction in age-adjusted annual gynecologic cancer mortality among women ages 15 to 64 from 9.9 to 8.6 per 100,000, although there was a slight increase in uterine cancer mortality (1.8/100,000 to 2.5/100,000). States that expanded Medicaid, vs those that did not, exhibited reductions in gynecologic cancer mortality, specifically from uterine and cervical diseases. This is possibly due to enhanced access to screening and treatment.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries